Ustekinumab-Ttwe Drug Interactions: 2 Major, 820 Moderate
Ustekinumab-Ttwe Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ustekinumab-Ttwe. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Ustekinumab.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Ustekinumab.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Ustekinumab is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Ustekinumab is combined with Abiraterone.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Ustekinumab is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Ustekinumab.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Ustekinumab.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Ustekinumab.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Ustekinumab is combined with Aceclofenac.
Level 2 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Ustekinumab.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Ustekinumab.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Ustekinumab.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Ustekinumab-Ttwe
Ustekinumab-Ttwe has 969 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ustekinumab-Ttwe has 2 major, 820 moderate, and 147 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ustekinumab-Ttwe. Always confirm against the full prescribing information.